Trump’s Administration Partners with AstraZeneca for COVID-19 Antibodies’ Manufacture
Trump’s administration entered into an agreement with AstraZeneca for late-stage and large scale manufacture of AZD7442, a combination of two monoclonal antibodies that treats or prevents SARS-CoV-2, according to press…